Admedus 2020 AGM

Our CEO Wayne Paterson presenting on the vision for Admedus at this years Annual General Meeting in Brisbane, Australia


Admedus 2019 AGM

A copy of the Admedus Annual General Meeting presentation for the period July-December 2017 can be downloaded here (file size 5.3MB) and a video of the meeting can be viewed here.


Admedus 2018 AGM Presentation

Admedus 2018 AGM

The investor webinar from our AGM on 16 November 2017 is now available to view.

Admedus 2017 AGM

2019 Annual Report

2019

2018 Annual Report

2018

2017 Annual Report (Jul 16 - Jun 17)

2017 Annual Report (Jul 17 - Dec 17)

2017

2016 Annual Report

2016

2015 Annual Report

2015

Anteris an Australian company’s innovative bid to transform heart valve technology

The New Daily Podcast by John Elder with Prof Leon Neethling & Wayne Paterson

DurAVR™ Key Opinion Leader Summary

CEO Presentation Deck

TAVR Key Opinion Leader Symposium

U.S. Medical Supplies & Devices TAVR KOL Symposium: Insights on Durability and the Future of TAVR
Credit Suisse Research Note

 Credit Suisse Research Note

The $5 billion market for valves to treat aortic stenosis, the most common heart valve disease, has the potential to double by 2025.

CEO of Anteris Technologies, Wayne Paterson, was live with us and says the key points of difference for the Anteris valve are the anti-calcification feature and unique design.

This innovation avoids the need for open-heart surgery, reducing the amount of time it requires for a patient to recover.

CEO Wayne Paterson is interviewed by Ausbiz

Anteris Technologies TAVR Advisory Board Signals High Level Interest

Bioshares July 2020 Report

Anteris Technologies Ltd's (ASX:AVR) Wayne Paterson tells Proactive's Andrew Scott the recent name change from Admedus is to reflect the single focus they have on structural heart and leveraging its assets into much more higher-value propositions. Paterson updates on its main trials which are underway and says he's extremely thrilled with the results to date from its first-in-human study. Paterson's expecting the company will end the year achieving all milestones set for 2020.

AVR: $0.00

0.00 (0%)

Invalid date AEST

Investor Centre

Investor News

13th Sep 2020

10th Aug 2020

9th Aug 2020

22nd Jul 2020

21st Jul 2020

19th Jul 2020

5th Jul 2020

23rd Jun 2020

Why Invest?

ASX Announcements

Financial Reports

Research Reports

View

View

View

View

Annual General Meetings

14th May 2020

16th May 2019

23rd May 2018

16th Nov 2017

Share Registry